Handelsbanken Fonder
IONS icon

Handelsbanken Fonder’s Ionis Pharmaceuticals IONS Stock Holding History

Handelsbanken Fonder’s Portfolio IONS Stock Details IONS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$30.4M Buy
383,211
+169,300
+79% +$12.7M 0.09% 200
2026
Q1 		$16.1M Buy
213,911
+166,000
+346% +$13.1M 0.05% 277
2025
Q4 		$3.79M Sell
47,911
-4,000
-8% -$301K 0.01% 548
2025
Q3 		$3.4M Buy
51,911
+8,700
+20% +$425K 0.01% 568
2025
Q2 		$1.71M Hold
43,211
– – 0.01% 721
2025
Q1 		$1.3M Sell
43,211
-600
-1% -$19.6K 0.01% 831
2024
Q4 		$1.53M Buy
43,811
+800
+2% +$29.9K 0.01% 780
2024
Q3 		$1.72M Buy
43,011
+9,100
+27% +$423K 0.01% 717
2024
Q2 		$1.62M Hold
33,911
– – 0.01% 650
2024
Q1 		$1.47M Buy
33,911
+6,900
+26% +$329K 0.01% 691
2023
Q4 		$1.37M Buy
27,011
+3,200
+13% +$153K 0.01% 675
2023
Q3 		$1.08M Sell
23,811
-6,900
-22% -$285K 0.01% 695
2023
Q2 		$1.26M Buy
30,711
+12,200
+66% +$469K 0.01% 655
2023
Q1 		$662K Hold
18,511
– – ﹤0.01% 868
2022
Q4 		$699K Hold
18,511
– – ﹤0.01% 782
2022
Q3 		$819K Hold
18,511
– – 0.01% 728
2022
Q2 		$685K Buy
18,511
+4,800
+35% +$181K ﹤0.01% 832
2022
Q1 		$508K Sell
13,711
-10,700
-44% -$350K ﹤0.01% 1202
2021
Q4 		$743K Hold
24,411
– – ﹤0.01% 1079
2021
Q3 		$819K Hold
24,411
– – ﹤0.01% 1026
2021
Q2 		$974K Buy
24,411
+1,400
+6% +$54.8K 0.01% 937
2021
Q1 		$1.03M Sell
23,011
-3,600
-14% -$201K 0.01% 826
2020
Q4 		$1.5M Buy
26,611
+4,300
+19% +$214K 0.01% 678
2020
Q3 		$1.06M Hold
22,311
– – 0.01% 708
2020
Q2 		$1.31M Buy
+22,311
New +$1.24M 0.01% 612

Other funds holding IONS

DC
Davenport & Co Richmond, Virginia $20.4B AUM 18.11% 1-Year Est. Return
HP
HealthInvest Partners Stockholm, Sweden $372M AUM 59.89% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
CUAMC
China Universal Asset Management Company Shanghai, China $1.67B AUM 89% 1-Year Est. Return
PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
FISPB
Fideuram - Intesa Sanpaolo Private Banking Turin $3.33B AUM
WMA
West Michigan Advisors Holland, Michigan $455M AUM 31.82% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
ETC
Exchange Traded Concepts Oklahoma City, Oklahoma $21.9B AUM 68.6% 1-Year Est. Return

Handelsbanken Fonder's IONS Position: Q2 2026 in Review

Handelsbanken Fonder increased its Ionis Pharmaceuticals (IONS) stake by 79% in Q2 2026, buying an estimated $12.7M and bringing the position to 383,211 shares worth $30.4M. The position accounts for 0.09% of the portfolio, ranked #200.

Handelsbanken Fonder first reported a position in IONS in Q2 2020 and has held it in 25 quarters since. 94 funds tracked by Wall St. Rank hold IONS as of Q2 2026.

  • Handelsbanken Fonder held 383,211 shares of Ionis Pharmaceuticals worth $30.4M as of Q2 2026.
  • Handelsbanken Fonder bought 169,300 Ionis Pharmaceuticals shares in Q2 2026, an estimated $12.7M.
  • Ionis Pharmaceuticals made up 0.09% of Handelsbanken Fonder's portfolio in Q2 2026, its #200 holding.
  • Handelsbanken Fonder first reported a position in Ionis Pharmaceuticals in Q2 2020 and has held it in 25 quarters since.
  • 94 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q2 2026.

Based on Handelsbanken Fonder's 13F filing for Q2 2026, filed 10 Jul 2026.